🔍 Intelligence Synthesis JP/EN
Ethics · Regulation · Technology — Pharma Practice Notes

AI and Neurological Rare & Neuroimmune Diseases ── ALS ── 2026-11-19

1 ALS papers. Lead: Speech-Based Dysarthria Severity Classification in Amyotrophic Lateral Sclerosis: A Controlled Deep Learning Benchmark

Journals covered and how papers are chosen: see the index

ALS: treatment, trials and AI

← Back to this issue